Skip to content
Open access · OA via Europe PMC

Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers.

D'Aversa E, Grisafi M, Pernagallo S, Salvatori F, Singh AV, Nucciarone A, Tisato V, Gemmati D.

Frontiers in aging neuroscience · 2026

Abstract

Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder that represents the leading cause of dementia worldwide, affecting over 50 million people. This global burden is expected to rise dramatically over the coming decades because of global population aging, representing a public health concern. Despite significant advances in understanding AD pathophysiology, early diagnosis remains challenging, emphasizing the urgent need for novel, reliable diagnostic and predictive biomarkers capable of identifying individuals at risk of progression during the preclinical stages of the disease. Growing evidence indicates that epigenetics constitutes a dynamic interface through which aging and environmental exposures influence gene expression and cellular homeostasis, thereby contributing to AD susceptibility and progression. The present review summarizes current knowledge on the epigenetic landscape of AD, from canonical epigenetic mechanisms, including aberrant DNA methylation, histone modifications, and non-coding RNAs (ncRNAs), to the emerging role of mitoepigenetics and RNA methylation in disease-associated molecular mechanisms. Finally, we discuss the potential of epigenetic alterations as promising innovative biomarkers of AD, providing insights into novel avenues for diagnostic and therapeutic intervention.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
Europe PMC
DOI
10.3389/fnagi.2026.1959361
Canonical
link ↗
Fetched
2026-10-22 MST

Cite this

APA
E, D., M, G., S, P., F, S., AV, S., A, N., V, T., &amp; D., G. (2026). Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers. <em>Frontiers in aging neuroscience</em>. https://doi.org/10.3389/fnagi.2026.1959361
Vancouver
E D, M G, S P, F S, AV S, A N, et al. Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers. Frontiers in aging neuroscience. 2026. doi:10.3389/fnagi.2026.1959361.
BibTeX
@article{daversa2026Epigen, title = {Epigenetics in Alzheimer's disease: from molecular mechanisms to emerging novel biomarkers.}, author = {D'Aversa E and Grisafi M and Pernagallo S and Salvatori F and Singh AV and Nucciarone A and Tisato V and Gemmati D.}, journal = {Frontiers in aging neuroscience}, year = {2026}, doi = {10.3389/fnagi.2026.1959361}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings